Accordingly, reducing proximal tubular Na+ reabsorption by blocking the activity of sodium-glucose cotransporter 2 (SGLT2), leads to a reduction in GFR in humans with diabetes-associated hyperfiltration [7] and in both total and single nephron GFR in rodents with diabetes [8]. Here, SLC5A2 is linked to diabetes mellitus.